P01130 (LDLR_HUMAN) Homo sapiens (Human)

Low-density lipoprotein receptor UniProtKBInterProSTRINGInteractive Modelling

860 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6)

Available Structures

32 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation Heteromer
Q8NBP7;
276-715
CA;
Assess
The X-ray Crystal Structure of PCSK9 in Complex with the LDL receptor Heteromer
Q8NBP7;
276-713
CA;
Assess
The structure of the LDLR/PCSK9 complex reveals the receptor in an extended conformation Heteromer
Q8NBP7;
316-715
CA;
Assess
Structure of a Complex Between the Pair of the LDL Receptor Ligand-Binding Modules 3-4 and the Rece… Heteromer
P30533;
107-184
NA;MPD;CA;
Assess
VSV G CR2 Heteromer
B7UCZ5;
65-106
NAG;CA;GOL;
Assess
WT PCSK9-deltaC bound to EGF-A H306Y mutant of LDLR Heteromer
Q8NBP7;
314-354
CA;
Assess
WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR Heteromer
Q8NBP7;
314-354
CA;
Assess
PCSK9-deltaC D374H mutant bound to WT EGF-A of LDLR Heteromer
Q8NBP7;
314-353
CA;
Assess
PCSK9:EGF-A complex Heteromer
Q8NBP7;
314-353
CA;
Assess
PCSK9-deltaC D374A mutant bound to WT EGF-A of LDLR Heteromer
Q8NBP7;
314-353
CA;
Assess
PCSK9-deltaC D374Y mutant bound to WT EGF-A of LDLR Heteromer
Q8NBP7;
314-353
CA;
Assess
PCSK9:EGFA(H306Y) Heteromer
Q8NBP7;
314-353
CA;
Assess
PCSK9:EGFA (pH 7.4) Heteromer
Q8NBP7;
314-353
CA;
Assess
Structure of a complex between domain V of beta2-glycoprotein I and the fourth ligand-binding modul… Heteromer
P02749;
147-184
CA;
Assess
VSV G CR3 Heteromer
P0C2X0;
108-144
NAG;NAG;CA;
Assess
PCSK9 in complex with LDLR peptide Heteromer
Q8NBP7;
314-339
NAG;CA;
Assess
Crystal structure of the LDL receptor tail in complex with autosomal recessive hypercholesterolemia… Heteromer
D3ZAR1;
820-832
Assess
Extracellular domain of the LDL receptormonomer65-714
NAG;NAG;CA;KEG;
Assess
Crystal Structure of the LDL Receptor YWTD-EGF Domain Pairmonomer398-713
Assess
Solution structure of LA45 from LDLRmonomer144-235
CA;
Assess
NMR STRUCTURE OF A CONCATEMER OF THE FIRST AND SECOND LIGAND-BINDING MODULES OF THE HUMAN LDL RECEP…monomer21-104
CA;
Assess
SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW D…monomer314-395
CA;
Assess
SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OF EGF-HOMOLOGY MODULES OF THE HUMAN LOW D…monomer314-395
CA;
Assess
Solution structure of the LA7-EGFA pair from the LDL receptormonomer272-353
CA;
Assess
NMR study of a pair of LDL receptor Ca2+ binding epidermal growth factor-like domains, 20 structuresmonomer314-393
CA;
Assess
THREE-DIMENSIONAL STRUCTURE OF A CYSTEINE-RICH REPEAT FROM THE LOW-DENSITY LIPOPROTEIN RECEPTORmonomer22-67
Assess
SECOND REPEAT OF THE LDL RECEPTOR LIGAND-BINDING DOMAINmonomer64-104
Assess
LDL RECEPTOR LIGAND-BINDING MODULE 6monomer233-272
CA;
Assess
NMR STRUCTURE OF THE SIXTH LIGAND-BINDING MODULE OF THE LDL RECEPTORmonomer234-272
CA;
Assess
RXFP1 utilises hydrophobic moieties on a signalling surface of the LDLa module to mediate receptor …monomer67-104
CA;
Assess
LDL RECEPTOR LIGAND-BINDING MODULE 5, CALCIUM-COORDINATINGmonomer196-232
SO4;CA;
Assess
Truncated EGF-Amonomer314-339
CA;
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3m0c.1.Cmonomer0.74276-713
CA;100.00
Assess
8em7.1.Amonomer0.6027-826
NGA;33.07
Assess
8em7.1.Amonomer0.6024-832
33.84
Assess
1n7d.1.Amonomer0.5965-714
CA;KEG;99.71
Assess
8em4.1.Amonomer0.5624-832
NGA;CA;33.84
Assess
8em4.1.Amonomer0.5427-826
33.07
Assess

25 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23m0c.1.Cmonomer0.78149-535
CA;92.44
Assess
Isoform 21f5y.1.Amonomer0.6023-104
CA;100.00
Assess
Isoform 21n7d.1.Amonomer0.5826-555
CA;KEG;87.50
Assess
Isoform 33m0c.1.Cmonomer0.75108-545
CA;92.88
Assess
Isoform 38ffe.1.Amonomer0.67230-487
27.20
Assess
Isoform 31n7d.1.Amonomer0.6165-546
CA;KEG;93.54
Assess
Isoform 38em7.1.Amonomer0.6125-682
29.87
Assess
Isoform 38em4.1.Amonomer0.6166-682
29.87
Assess
Isoform 38em7.1.Amonomer0.6024-682
29.87
Assess
Isoform 38em4.1.Amonomer0.5824-682
29.87
Assess
Isoform 43m0c.1.Cmonomer0.75235-672
CA;99.87
Assess
Isoform 41n7d.1.Amonomer0.5924-673
CA;KEG;96.01
Assess
Isoform 53m0c.1.Cmonomer0.73276-713
CA;100.00
Assess
Isoform 51n7d.1.Amonomer0.6065-714
CA;KEG;99.71
Assess
Isoform 58em7.1.Amonomer0.6027-826
NGA;33.07
Assess
Isoform 58em7.1.Amonomer0.5924-832
33.84
Assess
Isoform 58em4.1.Amonomer0.5624-832
NGA;CA;33.84
Assess
Isoform 58em4.1.Amonomer0.5427-826
33.07
Assess
Isoform 63m0c.1.Cmonomer0.77155-592
CA;99.38
Assess
Isoform 61n7d.1.Amonomer0.6327-593
CA;KEG;98.95
Assess
Isoform 68s9p.1.Bmonomer0.63231-729
29.26
Assess
Isoform 68em4.1.Amonomer0.62113-729
30.42
Assess
Isoform 68em7.1.Amonomer0.5924-729
30.42
Assess
Isoform 68em7.1.Amonomer0.5925-729
CA;31.56
Assess
Isoform 68em4.1.Amonomer0.5825-729
31.56
Assess